These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1708943)

  • 1. Novel effect of cyclicization of the Arg-Gly-Asp-containing peptide on vitronectin binding to platelets.
    Mohri H; Hashimoto Y; Ohba M; Kumagai H; Ohkubo T
    Am J Hematol; 1991 May; 37(1):14-9. PubMed ID: 1708943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets.
    Chen CS; Papayannopoulos IA; Timmons S; Chou SH; Thiagarajan P
    Biochim Biophys Acta; 1991 Oct; 1075(3):237-47. PubMed ID: 1720019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How vitronectin binds to activated glycoprotein IIb-IIIa complex and its function in platelet aggregation.
    Mohri H; Ohkubo T
    Am J Clin Pathol; 1991 Nov; 96(5):605-9. PubMed ID: 1719797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
    Plow EF; Pierschbacher MD; Ruoslahti E; Marguerie GA; Ginsberg MH
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8057-61. PubMed ID: 3877935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of thrombin-activated platelets with extracellular matrices (fibronectin and vitronectin): comparison of the activity of Arg-Gly-Asp-containing venom peptides and monoclonal antibodies against glycoprotein IIb/IIIa complex.
    Sheu JB; Ko WC; Hung WC; Peng HC; Huang TF
    J Pharm Pharmacol; 1997 Jan; 49(1):78-84. PubMed ID: 9120775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by Pro1743 and other amino acid residues adjacent to the sequence Arg1744-Gly1745-Asp1746.
    Berliner S; Niiya K; Roberts JR; Houghten RA; Ruggeri ZM
    J Biol Chem; 1988 Jun; 263(16):7500-5. PubMed ID: 2453507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclic Arg-Gly-Asp-containing peptide on fibronectin binding to activated platelets; role of fibronectin on platelet aggregation.
    Mohri H; Ohkubo T
    Peptides; 1993; 14(5):861-5. PubMed ID: 8284262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
    Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.
    Lawrence JB; Kramer WS; McKeown LP; Williams SB; Gralnick HR
    J Clin Invest; 1990 Nov; 86(5):1715-22. PubMed ID: 2243140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors.
    Pytela R; Pierschbacher MD; Ginsberg MH; Plow EF; Ruoslahti E
    Science; 1986 Mar; 231(4745):1559-62. PubMed ID: 2420006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peptide Glu-His-Ile-Pro-Ala binds fibrinogen and inhibits platelet aggregation and adhesion to fibrinogen and vitronectin.
    Gartner TK; Taylor DB
    Proc Soc Exp Biol Med; 1991 Oct; 198(1):649-55. PubMed ID: 1716370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibronectin inhibits platelet aggregation independently of RGD sequence.
    Tanabe J; Fujita H; Iwamatsu A; Mohri H; Ohkubo T
    J Biol Chem; 1993 Dec; 268(36):27143-7. PubMed ID: 8262952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF; Liu CZ; Ouyang CH; Teng CM
    Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly constrained cyclic (S,S) -CXaaC- peptides as inhibitors of fibrinogen binding to platelets.
    Kouki A; Mitsios JV; Sakarellos-Daitsiotis M; Sakarellos C; Tselepis AD; Tsikaris V; Tsoukatos DC
    J Thromb Haemost; 2005 Oct; 3(10):2324-30. PubMed ID: 16129021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cation-dependent changes in the binding specificity of the platelet receptor GPIIb/IIIa.
    Kirchhofer D; Gailit J; Ruoslahti E; Grzesiak J; Pierschbacher MD
    J Biol Chem; 1990 Oct; 265(30):18525-30. PubMed ID: 2211716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of specific antibodies directed to the binding domain of adhesive molecules.
    Berliner SA; Roberts JR; Thorn ML; Ruggeri ZM
    Pept Res; 1988; 1(2):60-4. PubMed ID: 2485226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides.
    Gehlsen KR; Argraves WS; Pierschbacher MD; Ruoslahti E
    J Cell Biol; 1988 Mar; 106(3):925-30. PubMed ID: 2450101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.